Duke-Margolis event to explore state of real-world evidence policy

Written by The Evidence Base
Events coverage Health policy News Real-world evidence

On July 25, 2024, the Duke-Margolis Institute for Health Policy will hold their annual public event discussing their latest activities within real-world data and real-world evidence (RWD/E) policy developments. 

The ‘2024 Duke-Margolis Convening on the State of Real-World Evidence Policy’ will take place virtually on Thursday, July 25, 2024 (12 – 4:45 PM ET).

This year, the event will focus on several key topics:

  • Barriers to accessing high-quality RWD for regulatory decisions: Discussing the challenges and potential solutions in obtaining reliable RWD for regulatory purposes.
  • Applications of artificial intelligence (AI) in RWE studies: Exploring how AI can enhance the accuracy and efficiency of RWE for regulatory use.
  • Opportunities to leverage RWD and RWE for informing payment and coverage decisions on novel technologies: Highlighting how RWE can influence policy and decision-making in health care.

Attendees will also hear about the latest initiatives from the Duke-Margolis Real-World Evidence Collaborative, including recent white papers and the International Harmonization of RWE Standards Dashboard.

Speakers at the event include:

  • Mark McClellan, Duke-Margolis Institute for Health Policy
  • Nicholaas Honig, Aetion, Inc.
  • Dena Jaffe, Oracle Health
  • Hussein Ezzeldin, US FDA
  • Joe Franklin, Verily Life Sciences
  • Inmaculada Hernandez, University of California San Diego

To learn more about speakers, topics of discussion, and how to register visit here: https://duke.is/w/ahyn.

Hear from The Evidence Base

Our Executive Editor, Joanne Walker, will be speaking at the event next week. Jo will join Rachele Hendricks-Sturrup (Duke-Margolis Institute for Health Policy) and Laura DiAngelo (AgencyIQ) during a Fireside Chat exploring the latest trends, developments and potential next steps for RWD and RWE.